Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?

Author:

Uchmanowicz Izabella1,Hoes Arno2,Perk Joep3,McKee Gabrielle4,Svavarsdóttir Margrét Hrönn5,Czerwińska-Jelonkiewicz Katarzyna6,Janssen Arne7,Oleksiak Anna8,Dendale Paul9,Graham Ian M10

Affiliation:

1. Faculty of Health Sciences, Wroclaw Medical University, Poland

2. Department of General Practice, University Medical Center Utrecht, The Netherlands

3. Faculty of Health and Life Sciences, Linnaeus University, Sweden

4. School of Nursing and Midwifery, Trinity College Dublin, Ireland

5. School of Health Sciences, University of Akureyri, Iceland

6. Center for Cardiovascular Research and Development, American Heart of Poland Inc., Poland

7. Clinical Research Department Cardiology, Heartcentre Hasselt, Belgium

8. Department of Intensive Cardiac Therapy, Institute of Cardiology, Poland

9. Heart Centre Hasselt, Jessa Hospital and Hasselt University, Belgium

10. Trinity College Dublin, Ireland

Abstract

Abstract Cardiovascular disease is a model example of a preventable condition for which practice guidelines are particularly important. In 2016, the joint task force created by the European Society of Cardiology (ESC) together with 10 other societies released the new version of the European guidelines on cardiovascular disease prevention. To facilitate the implementation of the ESC guidelines, a dedicated prevention implementation committee has been established within the European Association of Preventive Cardiology. The paper will first explore potential barriers to the guidelines’ implementation. It then develops a discussion that seeks to inform the future development of the committee’s work, including a new definition of the guidelines’ stakeholders (health policy-makers, healthcare professionals and health educators, patient organisations, entrepreneurs and the general public), future activities within four specific areas: strengthening awareness of the guidelines among stakeholders; supporting organisational changes to facilitate the guidelines’ implementation; motivating stakeholders to utilise the guidelines; and present ideas on new implementation strategies. Providing multifaceted cooperation between healthcare professionals, healthcare management executives and health policy-makers, the novel approach proposed in this paper should contribute to a wider use of the 2016 ESC guidelines and produce desired effects of less cardiovascular disease morbidity and mortality. Furthermore, the solutions presented within the paper may constitute a benchmark for the implementation of practice guidelines in other medical disciplines.

Funder

European Society of Cardiology (ESC) prevention of cardiovascular disease programme which is led by the European Association of Preventive Cardiology

Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions

Amgen

AstraZeneca

Ferrer and Sanofi and Regeneron in the form of educational

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3